BRI-CHEM CORP (BRY.CA) Fundamental Analysis & Valuation

TSX:BRY • CA10778T1057

Current stock price

0.25 CAD
0 (0%)
Last:

This BRY.CA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

1

1. BRY.CA Profitability Analysis

1.1 Basic Checks

  • BRY had negative earnings in the past year.
  • BRY had a positive operating cash flow in the past year.
  • In multiple years BRY reported negative net income over the last 5 years.
  • The reported operating cash flow has been mixed in the past 5 years: BRY reported negative operating cash flow in multiple years.
BRY.CA Yearly Net Income VS EBIT VS OCF VS FCFBRY.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M -10M 20M

1.2 Ratios

  • BRY's Return On Assets of -3.45% is on the low side compared to the rest of the industry. BRY is outperformed by 91.67% of its industry peers.
  • BRY's Return On Equity of -8.61% is on the low side compared to the rest of the industry. BRY is outperformed by 91.67% of its industry peers.
Industry RankSector Rank
ROA -3.45%
ROE -8.61%
ROIC N/A
ROA(3y)1.89%
ROA(5y)-2.15%
ROE(3y)7.6%
ROE(5y)-2.84%
ROIC(3y)N/A
ROIC(5y)N/A
BRY.CA Yearly ROA, ROE, ROICBRY.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 -40

1.3 Margins

  • BRY has a worse Gross Margin (17.27%) than 66.67% of its industry peers.
  • BRY's Gross Margin has been stable in the last couple of years.
  • BRY does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 17.27%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-4.96%
GM growth 5Y-0.62%
BRY.CA Yearly Profit, Operating, Gross MarginsBRY.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 20

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

2

2. BRY.CA Health Analysis

2.1 Basic Checks

  • BRY does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • The number of shares outstanding for BRY remains at a similar level compared to 1 year ago.
  • BRY has more shares outstanding than it did 5 years ago.
  • BRY has a better debt/assets ratio than last year.
BRY.CA Yearly Shares OutstandingBRY.CA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M
BRY.CA Yearly Total Debt VS Total AssetsBRY.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M

2.2 Solvency

  • BRY has an Altman-Z score of 1.54. This is a bad value and indicates that BRY is not financially healthy and even has some risk of bankruptcy.
  • The Altman-Z score of BRY (1.54) is worse than 83.33% of its industry peers.
  • The Debt to FCF ratio of BRY is 4.10, which is a neutral value as it means it would take BRY, 4.10 years of fcf income to pay off all of its debts.
  • BRY has a Debt to FCF ratio (4.10) which is in line with its industry peers.
  • BRY has a Debt/Equity ratio of 0.93. This is a neutral value indicating BRY is somewhat dependend on debt financing.
  • The Debt to Equity ratio of BRY (0.93) is worse than 83.33% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.93
Debt/FCF 4.1
Altman-Z 1.54
ROIC/WACCN/A
WACC8.63%
BRY.CA Yearly LT Debt VS Equity VS FCFBRY.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M -10M 20M

2.3 Liquidity

  • BRY has a Current Ratio of 1.48. This is a normal value and indicates that BRY is financially healthy and should not expect problems in meeting its short term obligations.
  • BRY's Current ratio of 1.48 is on the low side compared to the rest of the industry. BRY is outperformed by 83.33% of its industry peers.
  • A Quick Ratio of 0.60 indicates that BRY may have some problems paying its short term obligations.
  • With a Quick ratio value of 0.60, BRY is not doing good in the industry: 91.67% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 1.48
Quick Ratio 0.6
BRY.CA Yearly Current Assets VS Current LiabilitesBRY.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

0

3. BRY.CA Growth Analysis

3.1 Past

  • The Earnings Per Share has been growing slightly by 7.78% over the past year.
  • BRY shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -11.17%.
  • BRY shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -1.96% yearly.
EPS 1Y (TTM)7.78%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%158.82%
Revenue 1Y (TTM)-11.17%
Revenue growth 3Y11.21%
Revenue growth 5Y-1.96%
Sales Q2Q%-17.22%

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
BRY.CA Yearly Revenue VS EstimatesBRY.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

More info and screens

Find the best growth stocksShow best growing peers

2

4. BRY.CA Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for BRY. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
BRY.CA Price Earnings VS Forward Price EarningsBRY.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

  • 75.00% of the companies in the same industry are cheaper than BRY, based on the Enterprise Value to EBITDA ratio.
  • BRY's Price/Free Cash Flow ratio is rather cheap when compared to the industry. BRY is cheaper than 100.00% of the companies in the same industry.
Industry RankSector Rank
P/FCF 1.44
EV/EBITDA 13.71
BRY.CA Per share dataBRY.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 2

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. BRY.CA Dividend Analysis

5.1 Amount

  • BRY does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

BRY.CA Fundamentals: All Metrics, Ratios and Statistics

BRI-CHEM CORP

TSX:BRY (3/27/2026, 7:00:00 PM)

0.25

0 (0%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryTrading Companies & Distributors
Earnings (Last)11-17
Earnings (Next)04-01
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners0.14%
Ins Owner ChangeN/A
Market Cap6.61M
Revenue(TTM)79.26M
Net Income(TTM)-1.68M
Analysts0
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.08
P/FCF 1.44
P/OCF 1.31
P/B 0.34
P/tB 0.34
EV/EBITDA 13.71
EPS(TTM)-0.06
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0.17
FCFY69.48%
OCF(TTM)0.19
OCFY76.34%
SpS3
BVpS0.74
TBVpS0.74
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -3.45%
ROE -8.61%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 17.27%
FCFM 5.79%
ROA(3y)1.89%
ROA(5y)-2.15%
ROE(3y)7.6%
ROE(5y)-2.84%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-4.96%
GM growth 5Y-0.62%
F-Score4
Asset Turnover1.62
Health
Industry RankSector Rank
Debt/Equity 0.93
Debt/FCF 4.1
Debt/EBITDA 18.07
Cap/Depr 37.43%
Cap/Sales 0.57%
Interest Coverage N/A
Cash Conversion 499.39%
Profit Quality N/A
Current Ratio 1.48
Quick Ratio 0.6
Altman-Z 1.54
F-Score4
WACC8.63%
ROIC/WACCN/A
Cap/Depr(3y)93.13%
Cap/Depr(5y)56.73%
Cap/Sales(3y)1.06%
Cap/Sales(5y)0.65%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)7.78%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%158.82%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-11.17%
Revenue growth 3Y11.21%
Revenue growth 5Y-1.96%
Sales Q2Q%-17.22%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-111.52%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y466.79%
FCF growth 3YN/A
FCF growth 5Y-15.31%
OCF growth 1Y58.13%
OCF growth 3YN/A
OCF growth 5Y-14.89%

BRI-CHEM CORP / BRY.CA Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for BRI-CHEM CORP?

ChartMill assigns a fundamental rating of 1 / 10 to BRY.CA.


What is the valuation status for BRY stock?

ChartMill assigns a valuation rating of 2 / 10 to BRI-CHEM CORP (BRY.CA). This can be considered as Overvalued.


Can you provide the profitability details for BRI-CHEM CORP?

BRI-CHEM CORP (BRY.CA) has a profitability rating of 1 / 10.